Recent advances in the development of tissue transglutaminase (TG2) inhibitors

Keyphrases

• Alzheimer's Disease 50%
• Biological Processes 50%
• Biological Properties 50%
• Ca2+ Activation 50%
• Ca2+ Dependence 50%
• Cancer Fibrosis 50%
• Cancer Types 50%
• Celiac Sprue 50%
• Cell-penetrating 100%
• Cell-to-cell 50%
• Cellular Level 50%
• Cellular Mechanisms 50%
• Cystic Fibrosis 50%
• Disease States 100%
• Future Therapeutics 50%
• Glutamine 50%
• Huntington's Disease 50%
• Isopeptide Bond 50%
• Lysine Residue 50%
• Multiple Sclerosis Treatment 50%
• Novel Therapeutics 50%
• Parkinson's Disease 50%
• Recent Advances 100%
• Selective Inhibitor 50%
• Structure-activity Relationship 50%
• TG2 Inhibitors 100%
• Therapeutic Development 50%
• Therapeutic Tool 50%
• Tissue Transglutaminase 100%
• Transglutaminase 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 33%
• Calcium Ion 66%
• Coeliac Disease 33%
• Cystic Fibrosis 33%
• Diseases 66%
• Fibrosis 33%
• Glutamine 33%
• Guanosine Triphosphate 33%
• Huntington Chorea 33%
• Isopeptide Bond 33%
• Lysine 33%
• Malignant Neoplasm 33%
• Multiple Sclerosis 33%
• Parkinson's Disease 33%
• Protein Glutamine Gamma Glutamyltransferase 100%
• Structure Activity Relationship 33%